Join global hematology leaders at Highlights of ASH in the Mediterranean, Middle East, and North Africa, a two-day program offered in Istanbul, Türkiye, to explore and discuss the most influential and novel research presented at the latest ASH annual meeting.
Highlights of ASH in the Mediterranean, Middle East, and North Africa
Register Today
Highlights of ASH in the Mediterranean, Middle East, and North Africa brings global hematology leaders together for two days in Istanbul, Türkiye. Discuss the most influential and novel research from the latest ASH annual meeting, spanning a wide range of topics. Connect with top experts in person and learn how to apply the latest research to your own work.
February 13-14, 2026
Venue: Hilton Istanbul Bomonti Hotel & Conference Center
Registration is now open!
“ASH Highlights is a good opportunity to share our expertise from the region to the world. I am most looking forward to scientific interaction and collaboration opportunities. Türkiye is a hemoglobinopathy country and I hope attendees take away the current diagnostic and treatment modalities.”
About Highlights of ASH
Note: The Highlights of ASH in the Mediterranean, Middle East, and North Africa program is presented in English.
Cutting-edge Research from Across Disciplines
Hear the most influential and novel research in malignant and classical hematology shared at the latest ASH annual meeting.
Instant Insights
Ask questions and get feedback from top hematology experts in real time.
Real Advice You Can Use
Gain insight into local and regional standards of care. Discover how emerging technology can enhance your practice.
Meet the World's Leading Hematology Experts
Get one-on-one interaction and tailored insights from leading experts in the field.
Career-Enhancing Networking and Mentorship Opportunities
Build partnerships, form new relationships, and reconnect with colleagues from your region.
Meeting Information
Certificate of Participation Information
Highlights of ASH in the Mediterranean, Middle East, and North Africa is planned to offer 12.25 contact hours and will take place on February 13-14, 2026. This activity will not provide CME credit to participants. To claim a Certificate of Participation, attendees must complete the online program evaluation surveys through ASH Academy on Demand. View Certificate of Participation Information| 8:00 a.m. - 8:45 a.m. | Registration and Exhibits Open |
| 8:45 a.m. - 9:00 a.m. | Welcome & Introduction |
| 9:00 a.m. - 9:30 a.m. | Old Dogs, New Tricks: Advances in Treatment of Autoimmune Diseases Anem Waheed, MD, MPH Weill Cornell Medicine New York, NY |
| 9:30 a.m. - 10:15 a.m. |
Updates on Hemoglobinopathies: Think Globally, Act Locally Lydia Pecker, MD, MHS John Hopkins Medicine Baltimore, MD Sule Unal Cangül, MD Hacettepe University Ankara, Türkiye |
| 10:15 a.m. - 10:45 a.m. | Panel Discussion |
| 10:45 a.m. - 11:15 a.m. | Coffee Break in the Exhibit Hall |
| 11:15 a.m. - 12:30 p.m. |
Tumor Board: Acute Myeloid Leukemia Moderator: John Molina, MD Jessica Altman, MD Ivana Gojo, MD Maria Teresa Voso, MD |
| 12:30 p.m. - 1:30 p.m. | Lunch in the Exhibit Hall |
| 1:30 p.m. - 2:00 p.m. | New Horizons in Transplantation and Cellular Therapies Robert Negrin, MD Stanford University Stanford, CA |
| 2:00 p.m. - 2:30 p.m. | The Times are A-Changin' in Myeloma: High-Risk Definitions, Frontline Induction, and Broader Bispecifics Rahul Banerjee, MD, FACP Fred Hutchinson Cancer Center Seattle, WA |
| 2:30 p.m. - 3:00 p.m. | Panel Discussion |
| 3:00 p.m. - 3:30 p.m. | Coffee Break in the Exhibit Hall |
| 3:30 p.m. - 4:00 p.m. | Managing Hemophilia Patients in 2026 Guy Young, MD University of Southern California Los Angeles, CA |
| 4:00 p.m. - 4:45 p.m. | Update in Obstetric Hematology Beverly Hunt, MD Guy's and St. Thomas' NHS Foundation Trust London, United Kingdom Ali Taher MD, PhD, FRCP American University of Beirut Beirut, Lebanon |
| 4:45 p.m. - 5:15 p.m. | Panel Discussion |
| 5:15 p.m. | Highlights of ASH® Day 1 Program Adjournment |
| 8:45 a.m. - 9:00 a.m. | Welcome & Introduction |
| 9:00 a.m. - 9:30 a.m. | Novel Agents and Combinations for Treatment of Aggressive Lymphoma Paolo Caimi, MD, MBA Cleveland Clinic Cleveland, OH |
| 9:30 a.m. - 10:00 a.m. | Advances in Chronic Lymphocytic Leukemia and Indolent B-Cell Lymphomas Tanya Siddiqi, MD City of Hope Irvine, CA |
| 10:00 a.m. - 10:30 a.m. | Panel Discussion |
| 10:30 a.m. - 11:00 a.m. | Coffee Break in the Exhibit Hall |
| 11:00 a.m. - 12:15 p.m. |
Turning the Tide: Key Cases and Conundrums in Thrombosis Medicine Reyhan Diz-Kucukkaya, MD
Scott C. Woller, MD |
| 12:15 p.m. - 1:30 p.m. | Lunch in the Exhibit Hall (All Attendees) |
| Lunch with the Experts (Ticketed) | |
| 1:30 p.m. - 2:00 p.m. | How I Treat ALL in 2026: Sequencing for Cure in the Era of Targeted and Novel Immune Therapies John Molina, MD, EdM Cleveland Clinic Cleveland, OH |
| 2:00 p.m. - 2:30 p.m. | Progress & Promise: Translating Innovation into Clinical Practice for MDS & MPN David Sallman, MD Moffitt Cancer Center Tampa, FL |
| 2:30 p.m. - 3:00 p.m. | Panel Discussion |
| 3:00 p.m. - 3:30 p.m. | Coffee Break in the Exhibit Hall |
| 3:30 p.m. - 4:00 p.m. | Pediatric Hematologic Malignancies: Refining Risk, Reducing Toxicity, and Reimagining Therapy Adam Lamble, MD Seattle Children's Hospital Seattle, WA |
| 4:00 p.m. - 4:30 p.m. | Artificial Intelligence and Informatics in Hematology: From Precision Diagnostics to Practice Transformation Amar Kelkar, MD Dana-Farber Cancer Institute Boston, MA |
| 4:30 p.m. - 5:00 p.m. | Panel Discussion |
| 5:00 p.m. | Highlights of ASH in the Mediterranean, Middle East, and North Africa Adjournment |
Program Coordinators
Program Co-Host
ASH is proud to co-host this meeting with the Turkish Society of Hematology.
Program Co-Chairs
The Program Co-Chairs for the Highlights of ASH in the Mediterranean, Middle East, and North Africa are:
- Turkish Society of Hematology Program Co-Chairs
- Dr. Özgür Mehtap
- Dr. Sule Cangül Unal
- American Society of Hematology Program Co-Chairs
- Dr. John Molina
- Dr. Rachel P. Rosovsky